Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.
Baohua HouZhenchong LiZuguang MaZixuan ZhouHongkai ZhuangChunsheng LiuBowen HuangYiping ZouZehao ZhengLinLing YangYuanfeng GongShanzhou HuangQi ZhouChuanzhao ZhangBao-Hua HouPublished in: BioMed research international (2021)
We constructed a risk model based on 6 KRAS-associated metabolic genes, which predicted patients' survival with high accuracy and reflected tumor metabolic characteristics and gemcitabine-associated chemoresistance in PC.